Correction of pyrimidine derivatives of immunologic activity of the organism and external respiration function for prevention of the lingering course of acute pneumonia



Cite item

Full Text

Open Access Open Access
Restricted Access Access granted
Restricted Access Subscription or Fee Access

Abstract

The effect of xymedon on immunologic indices and external respiration function in combined treatment of patients with acute pnemonia is studied. The use of xymedon in the presence of basis therapy in patients with lingering pneumonia with reduced immunologic reactivity exerts a stimulating effect on the indices of cellular and humoral immunity. This effect is revealed in the stabilization period of pneumonia accompanied by positive clinicoroentgenologic shifts, provides a higher increase of the indices of external respiration function, reduces the terms of recovery of patients. Xymedon does not cause side effects. The drug may be recommended for a wider use in the clinic in patients with unspecific diseases of the lungs.

Full Text

Restricted Access

About the authors

Yu. D. Slabnov

Kazan Institute for Advanced Training of Physicians named after V.I.Lenin

Author for correspondence.
Email: info@eco-vector.com
Russian Federation

D. A. Valimukhametova

Kazan Institute for Advanced Training of Physicians named after V.I.Lenin

Email: info@eco-vector.com
Russian Federation

A. P. Tsibulkin

Kazan Institute for Advanced Training of Physicians named after V.I.Lenin

Email: info@eco-vector.com
Russian Federation

R. F. Khamitov

Kazan Institute for Advanced Training of Physicians named after V.I.Lenin

Email: info@eco-vector.com
Russian Federation

References

  1. Беленький Е. Е., Рупихин Ю. А., Туницкая Т. А. Фармакологическая регуляция регенеративных процессов.—Йошкар-Ола, 1979.
  2. Горбунов С. М. Фармакотоксикологическая характеристика ксимедона и влияние его на заживление термических ожогов кожи: Автореф. дисс. канд. мед. наук.— Казань, 1979.
  3. Ермаков Е. В., Медников Б. Л., Чернов А. П. и др. Yep. арх.—1982.—№ 9.—С. 47— 50.
  4. Завражнов В. И. Материалы конференции по применению пиримидиновых производных в онкологии и других областях медицины,—Л., 1963.
  5. Зильбер Е. А., Шунько Б. Е. Тер. арх.—1981.—№ 3.—С. 87—91.
  6. Кочнев О. С., Измайлов С. Г. Казанский мед. ж,—1990.—№ 5,—С. 373—375.
  7. Сильевестров В. П., Караулов А. В., Тер. арх.—1984.—№ З.-С. 3—11.
  8. Сильвестров В. П., Федотов П. И. Пневмония.—М., 1987.
  9. Слабнов Ю. Д. Экспериментальное обоснование применения ксимедона как иммуномодулятора: Автореф. дисс. канд. мед. наук.—Казань, 1988.
  10. Хамитов X. С., Валимухаметова Д. А., Цибулькин А. П. и др. Ксимедон—Казань, 1986.
  11. Joticlal М., Holm J., Wigzel Н. А. exp. Med.—1972,—Vol. 136.—P. 207—215.
  12. Mancini I., Corbonaro A. 0., Heretnuns Q. S. Immunnochemistry.—1965.—Vol. 2,— P. 23—25.

© 1993 Slabnov Y.D., Valimukhametova D.A., Tsibulkin A.P., Khamitov R.F.

Creative Commons License

This work is licensed
under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.





This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies